Posters

Long-term outcomes with a trifocal multifocal intraocular lenses with and without a toric component

Poster Details

First Author: F. Kretz GERMANY

Co Author(s): M. Gerl   M. Muller   D. Breyer   H. Kaymak   K. Klabe   G. Auffarth     

Abstract Details

Purpose:

To evaluate the functional outcome after implantation of a trifocal MIOL in a bi-toric (AT LISA 939MP, Carl Zeiss Meditech, Germany) and a non-toric (AT LISA 839MP, Carl Zeiss Meditech, Germany) version over a time period of more than 2 years.

Setting:

Augenklinik Ahaus, Germany; Internationl Vision Correction Research Centre Network (IVCRC.net), Dept. of Ophthalmology, Univ. of Heidelberg

Methods:

Examinations included UDVA, UIVA, UNVA, CDVA, DCIVA and DCNVA [logMAR]. Additionally a Salzburg Reading Desk (SRD) evaluation (uncorrected and distance corrected) was performed.

Results:

In the toric group the median postoperative binocular UDVA, UIVA and UNVA were 0.02, 0.04 and 0.10 compared to a CDVA, DCIVA and DCNVA of 0.04, -0.10 and -0.10 [logMAR]. The non-toric group showed a UDVA, UIVA and UNVA of 0.06, 0.09 and 0.06 compared to a CDVA, DCIVA and DCNVA of 0.04, 0.00 and 0.06 [logMAR], respectively.

Conclusions:

Both MIOLs offer a restoration of the visual function in multiple distances. The bitoricity of the toric version additionally offers a good compensation for corneal astigmatism.

Financial Disclosure:

receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, travel has been funded, fully or partially, by a competing company, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, research is funded, fully or partially, by a competing company, research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, receives consulting fees, retainer, or contract payments from a competing company